Form 8-K - Current report:
SEC Accession No. 0001674796-24-000008
Filing Date
2024-05-03
Accepted
2024-05-03 16:42:34
Documents
15
Period of Report
2024-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 HST GLOBAL, INC. - FORM 8-K SEC FILING hstc-20231231.htm   iXBRL 8-K 44417
2 EXHIBIT 10.1 exhibit10-1.htm EX-10 67355
  Complete submission text file 0001674796-24-000008.txt   228434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hstc-20231231_def.xml EX-101.DEF 1848
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hstc-20231231_lab.xml EX-101.LAB 13830
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hstc-20231231_pre.xml EX-101.PRE 8966
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hstc-20231231.xsd EX-101.SCH 2310
19 EXTRACTED XBRL INSTANCE DOCUMENT hstc-20231231_htm.xml XML 2750
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Filer) CIK: 0000797564 (see all company filings)

EIN.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15303 | Film No.: 24913934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)